AI-powered, next-generation sequencing blood-based assay evaluated for detection of post-HCT relapse in AML and MDS (opens in new tab)

RNA sequencing and AI-powered blood monitoring may detect relapse earlier after hematopoietic cell transplantation, improving risk prediction in AML and myelodysplastic syndrome patients...